BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 31/07/2024

FDA Announces Prescription Drug User Fee Rates for Fiscal Year 2025

The Food and Drug Administration is setting the fees for reviewing prescription drugs and biological products for fiscal year 2025, as mandated by the Prescription Drug User Fee Amendments of 2022.

Source: Federal Register — Food and Drug AdministrationOpen original release →